Oxelumab is a human monoclonal antibody designed for the treatment of

asthma Asthma is a long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and easily triggered bronchospasms. Symptoms include episodes of wheezing, co ...

. Oxelumab was developed by Genentech and co-developed by

Roche F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX ...

References

Drugs developed by Hoffmann-La Roche Drugs developed by Genentech Experimental drugs {{antineoplastic-drug-stub